论文部分内容阅读
1993年3月8～13日国家计划生育委员会科学技术研究所、生殖医学杂志编委会联合举办了节育新技术学习班。参加本次学习班的正式学员主要为世界卫生组织人类生殖研究特别规划署组织的释放左旋18甲基炔诺酮20μgIUD和TCu380A IUD多中心比较性研究课题的参加单位,其中包括来自北京、上海、天津、南京及武汉等11个科研和医疗单位和朝鲜民主主义共和国的进修生,以及其他省市的旁听学员共计34名。学习班期间邀请了芬兰赫尔辛基大学著名科学家T.Luukkainen教授及其助手Dr J.Toivonen和P.Lahteenmaki以及赫尔辛基市妇产医院的主管护士M.Tikka女士,对他们近年来发展的激素缓释避孕系统的基础研究及临床试验情况进行了详尽的介绍。其中包括释放左旋18甲基炔诺酮20μg IUD皮下埋植(Norplant Ⅰ型和Ⅱ型)、释放左旋18甲基炔诺酮20μg的宫颈内节育器(ICD)及适用于哺乳妇女避孕的合成孕激素ST-1435。学习班还对释放左旋18甲基炔诺酮20μg IUD和皮下埋植的放置技术进行了示教和实习,强调正确的放置对提高避孕器
1993 March 8 ~ 13 National Family Planning Commission Institute of Science and Technology, Reproductive Medicine Editorial Board jointly organized a new class of birth control classes. Participants in this workshop are mainly participants in the comparative study on the release of levonorgestrel 20 μg IUD and TCu380A IUD from the Center for Human Reproductive Research of the World Health Organization, including participants from Beijing, Shanghai, Tianjin, Nanjing and Wuhan 11 research and medical units and the DPRK Democratic students, as well as other provinces and municipalities to attend a total of 34 participants. During the class, Prof. T. Lukkainen and his assistants Dr. T. Tuivonen and P.Lahteenmaki, renowned scientists from the University of Helsinki, Finland, and Ms. M. Tikka, the chief nurse of Helsinki Maternity Hospital, were invited to discuss their recent progress in the development of hormone-releasing contraceptive systems The basic research and clinical trials conducted a detailed introduction. These include intrauterine devices (ICDs) that release 20 μg of levonorgestrel 20 μg IUD subcutaneously (Norplant type I and type II), intrauterine device (ICD) that release 20 μg of levonorgestrel 20 μg and contraception for lactating women Hormone ST-1435. The course also taught and interned the release of 20 μg IUD 18 μg norgestrel and subcutaneous implants, emphasizing the proper placement of the device to enhance contraception